Evidence map›Paper›PMID 42281523›Full record

ArticleAnnals of clinical and translational neurology2026

Thalamo-Lesional Connectivity Signatures of Bilateral Tonic-Clonic Seizures in Focal Cortical Dysplasia-Related Epilepsy.

Hua Xie, Xiaotong Li, Venkata Sita Priyanka Illapani, Leigh N Sepeta, Jason Schroeder, Chima O Oluigbo, Madison M Berl, William D Gaillard, Nathan T Cohen

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hua XieCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0003-3462-0147
Xiaotong LiCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Venkata Sita Priyanka IllapaniCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Leigh N SepetaCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Jason SchroederCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Chima O OluigboCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Madison M BerlCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0002-2469-1518
William D GaillardCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
Nathan T CohenCenter for Neuroscience Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.ORCID https://orcid.org/0000-0002-1410-3487

Funding

Neurobehavioral Evaluation CoreP50HD105328 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI LAUREN KENWORTHY · 2021 to 2026
$9.3M
Determining network signatures of pharmacoresistance in focal cortical dysplasia-related epilepsyK23NS131522 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI Nathan Tyler Cohen · 2025 to 2026
$431k
American Academy of NeurologyAmerican Epilepsy SocietyHess FoundationNCATS NIH HHS P50 HD105328NICHD NIH HHS P50 HD105328NINDS NIH HHS K23 NS131522NINDS NIH HHS K23NS131522
6 · The paper itself

Abstract

objectivesFocal cortical dysplasia (FCD) is the most common etiology of drug-resistant epilepsy in children. Focal to bilateral tonic-clonic seizures (FBTCS) mark a high risk of drug-resistant epilepsy and involve thalamocortical circuitry in their generation and propagation. Using FCD as a model of focal epilepsy, we examined the integrity of thalamocortical circuitry to characterize thalamo-lesional connectivity signatures of FBTCS.

methodsForty-three patients (14 with FBTCS) range 5-22 years, and 116 age- and sex-matched healthy controls were included. A network-driven thalamic functional parcellation was developed in healthy controls using Yeo 7-network atlas. We calculated z-scored thalamo-lesional functional connectivity between thalamic functional parcels and dysplasia masks in reference to controls, which was used to classify the presence of FBTCS. Clinical associations of thalamo-lesional connectivity were evaluated.

resultsZ-scored thalamo-lesional connectivity classified the presence of FBTCS with a median accuracy of 0.72. The thalamic parcel preferentially connected to the somatomotor-network (SMN), comprising ventral-posterolateral, pulvinar-medial and intralaminar nuclei, contributed most to classification. Lower ipsilateral SMN-thalamus connectivity was related to postsurgical seizure freedom and preserved ipsilateral thalamic volume. SIGNIFICANCE: Thalamocortical circuitry was examined between the seizure generator (lesion) and the amplifier (thalamus) in FCD patients. FBTCS are associated with thalamo-lesional connectivity abnormalities that correlate to postsurgical outcomes, and demonstrate the SMN-thalamus as a primary gatekeeper for secondary generalization. The successful implementation of our classifier suggests that these thalamo-lesional signatures can serve as a potential neuromarker for seizure phenotyping, marking a step toward network-informed, personalized treatment.

Indexed as

connectomedrug‐resistant epilepsyepilepsy surgeryfocal cortical dysplasiafunctional MRImalformation of cortical development

Identifiers

PMID42281523
PMCPMC13394792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.